tory, metabolic, or cardiovascular markers. This suggests a need to address these comorbidities by offering combined treatment modalities. Programs aimed at reducing the detrimental consequences of obesity systematically target an increase in physical activity and a reduction in sedentary behaviors. In their recent work in patients with OHS, Murphy and colleagues 2 reported objective improvement in physical activity after 3 months of nocturnal NIV. This elegant study, including patients both in a stable state and in post-acute respiratory failure, compared two ven tilatory modes with a randomized control design. Therefore, all patients were exposed to NIV treatment. Thus, it is disputable whether weight loss and physical activity improvements were related to NIV per se or to lifestyle changes associated with inclusion in a clinical research protocol. Moreover, patients placed on NIV during post-acute respiratory failure were likely to have low physical activity at baseline, whereas a dramatic improvement in activity was expected after 3 months of recovery. Actually, obesity itself promotes limited physical activity and sedentary behavior partly because of exercise-related dyspnea. NIV during exercise training in rehabilitation programs might enhance exercise capacity by reducing the respiratory load in subjects who are morbidly obese. 3 Additionally, we have demonstrated that the training of respiratory muscles in subjects who are obese improves dyspnea and exercise capacity. 4 We are currently evaluating these tools in rehabilitation programs aimed at reducing cardiometabolic risks in obese subjects, 5 in addition to nocturnal NIV. NIV initiation could, thus, be the appropriate starting time for such integrated programs, although the best modalities to improve motivation and adherence have yet to be determined. 6 Future studies should not only evaluate the effi cacy of combining nocturnal NIV and rehabilitation programs, but also determine the rate of drop-outs and the cost-effectiveness of such combined strategies in OHS treatment. 
Concerns Raised by Lung Size-Mismatched Transplantation
To the Editor:
We read with great interest the article by Eberlein et al 1 in CHEST (February 2012), which concluded that an oversized lung allograft (predicted total lung capacity [pTLC] ratio . 1.0) was associated with higher expiratory airfl ow capacity and a less frequent occurrence of bronchiolitis obliterans syndrome when compared with an undersized allograft (pTLC ratio Յ 1.0). Undeniably, lung size mismatch is commonly encountered in pulmonary transplantation because donor allocation does not allow precise matching when a long list of patients is waiting for scarce donors. We are grateful to the authors for their important work. However, we would like to voice some signifi cant concerns about the study design that need clarifi cations.
A heterogeneous population of 159 patients undergoing transplant from two different centers (Johns Hopkins Hospital from January 1996 to March 2010 and Inova Fairfax Hospital from January 1996 to December 2008) was included in this retrospective study. However, no data were available to show the comparability between the two centers, and it is unknown if signifi cant bias was introduced by different transplant protocols, which play a vital role in the prognosis of these patients. As a consequence, potential confounding factors not accounted for, including recipient and donor characteristics, should have been compared between the two centers before a combined analysis was conducted; otherwise, a separate analysis for each center would be have been preferred.
The authors provide the pTLC ratio (donor pTLC/recipient pTLC) for their defi nition of size matching according to the regression equations. 2 Although we indeed agree that the pTLC ratio is widely used to match donors with recipients, it is wrong to suggest that the pTLC ratio is a reliable marker of size matching, as stated by the authors, because no reference range of pTLC ratio was raised to address the ideal status of size matching. From our perspective, oversized allografts implanted into the smaller thorax cavity can lead to atelectasis and impaired airway clearance because of bronchial anatomy distortion.
Increasing evidence suggests that size-reduced lung trans plants (graft volume reduction and lobar lung transplant) are benefi cial to recipients receiving oversized allografts. 3 , 4 Shigemura et al 5 investigated lung volume reduction as an effi cient tool for reducing short-term complications and improving pulmonary function in patients with size-mismatched allografts. A special approach for overcoming severe size disparities is lobar transplant, which is especially useful in pediatric lung transplants involving a small thorax cavity. Loizzi et al 6 suggested the pTLC ratio as a marker of lobar transplant based on a receiver operating characteristic analysis: Patients with oversized allografts (pTLC ratio . 1.2) were considered for a lobar transplant, for which the higher the pTLC ratio, the higher the possibility that the patients were likely to benefi t from it. Date et al 7 also stated that size disparity in lobar transplants can be accepted when the total FVC of the two grafts is . 50% of the predicted FVC of the recipient, estimated by the following formula: Total FVC of the two grafts 5 measured FVC of the right donor 3 5/19 1 measured FVC of the left donor 3 4/19 (the right lower lobe consists of fi ve segments, the left lower lobe of four, and the whole lung of 19). Date et al 7 suggested that in such a case, this is an alternative to conventional cadaveric lung transplant, resulting in a similar outcome. Additionally , comparable clinical outcomes were observed between patients who received size-matched allografts and size-reduced allografts. 4 , 8 However, the authors did not describe in the article the situation of size-reduced lung transplantation for an oversized cohort, implying that lung trimming as a confounding factor may result in signifi cant discrepancy. It would be helpful if this concern could be commented on, and further analysis of the study to address this important issue is required. 
